1
|
Manku G, Hueso A, Brimo F, Chan P,
Gonzalez-Peramato P, Jabado N, Gayden T, Bourgey M, Riazalhosseini
Y and Culty M: Changes in the expression profiles of claudins
during gonocyte differentiation and in seminomas. Andrology.
4:95–110. 2016. View Article : Google Scholar
|
2
|
Litchfield K, Summersgill B, Yost S,
Sultana R, Labreche K, Dudakia D, Renwick A, Seal S, Al-Saadi R,
Broderick P, et al: Whole-exome sequencing reveals the mutational
spectrum of testicular germ cell tumours. Nat Commun. 6:59732015.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Aran V, Victorino AP, Thuler LC and
Ferreira CG: Colorectal cancer: Epidemiology, disease mechanisms
and interventions to reduce onset and mortality. Clin Colorectal
Cancer. 15:195–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Taylor-Weiner A, Zack T, O'Donnell E,
Guerriero JL, Bernard B, Reddy A, Han GC, AlDubayan S, Amin-Mansour
A, Schumacher SE, et al: Genomic evolution and chemoresistance in
germ-cell tumours. Nature. 540:114–118. 2016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Liu T, Li R, Zhao H, Deng J, Long Y, Shuai
MT, Li Q, Gu H, Chen YQ and Leng AM: eIF4E promotes tumorigenesis
and modulates chemosensitivity to cisplatin in esophageal squamous
cell carcinoma. Oncotarget. 7:66851–66864. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chieffi P and Chieffi S: Molecular
biomarkers as potential targets for therapeutic strategies in human
testicular germ cell tumors: An overview. J Cell Physiol.
228:1641–1646. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Trabert B, Chen J, Devesa SS, Bray F and
McGlynn KA: International patterns and trends in testicular cancer
incidence, overall and by histologic subtype, 1973–2007. Andrology.
3:4–12. 2015. View
Article : Google Scholar
|
8
|
Gilligan TD, Seidenfeld J, Basch EM,
Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R
and Hayes DF; American Society of Clinical Oncology: American
Society of Clinical Oncology Clinical Practice Guideline on uses of
serum tumor markers in adult males with germ cell tumors. J Clin
Oncol. 28:3388–3404. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Murray MJ, Huddart RA and Coleman N: The
present and future of serum diagnostic tests for testicular germ
cell tumours. Nat Rev Urol. 13:715–725. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Hanna NH and Einhorn LH: Testicular cancer
- discoveries and updates. N Engl J Med. 371:2005–2016. 2014.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Sheikine Y, Genega E, Melamed J, Lee P,
Reuter VE and Ye H: Molecular genetics of testicular germ cell
tumors. Am J Cancer Res. 2:153–167. 2012.
|
12
|
Kanetsky PA, Mitra N, Vardhanabhuti S, Li
M, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J,
et al: Common variation in KITLG and at 5q31.3 predisposes to
testicular germ cell cancer. Nat Genet. 41:811–815. 2009.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Rijlaarsdam MA and Looijenga LH: An
oncofetal and developmental perspective on testicular germ cell
cancer. Semin Cancer Biol. 29:59–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
15
|
Consortium TGO: Gene ontology: tool for
the unification of biology. The Gene Ontology Consortium Nat Genet.
25:25–29. 2000.
|
16
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto Encyclopedia of Genes and Genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar
|
17
|
Köhler S, Bauer S, Horn D and Robinson PN:
Walking the interactome for prioritization of candidate disease
genes. Am J Hum Genet. 82:949–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Chia VM, Quraishi SM, Devesa SS, Purdue
MP, Cook MB and McGlynn KA: International trends in the incidence
of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev.
19:1151–1159. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cook MB, Akre O, Forman D, Madigan MP,
Richiardi L and McGlynn KA: A systematic review and meta-analysis
of perinatal variables in relation to the risk of testicular cancer
- experiences of the son. Int J Epidemiol. 39:1605–1618. 2010.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Peng J, Wu Y, Tian X, Pang J, Kuai L, Cao
F, Qin X, Zhong J, Li X, Li Y, et al: High-throughput sequencing
and co-expression network analysis of lncRNAs and mRNAs in early
brain injury following experimental subarachnoid haemorrhage. Sci
Rep. 7:465772017. View Article : Google Scholar : PubMed/NCBI
|
21
|
Jain A, Tripathi R, Turpin CP, Wang C and
Plattner R: Abl kinase regulation by BRAF/ERK and cooperation with
Akt in melanoma. Oncogene. Apr 3–2017.Epub ahead of print.
View Article : Google Scholar : 2017.
|
22
|
Chen L, Fu H, Luo Y, Chen L, Cheng R,
Zhang N and Guo H: cPLA2α mediates TGF-β-induced
epithelial-mesenchymal transition in breast cancer through PI3k/Akt
signaling. Cell Death Dis. 8:e27282017. View Article : Google Scholar
|
23
|
Liu N, Mei L, Fan X, Tang C, Ji X, Hu X,
Shi W, Qian Y, Hussain M, Wu J, et al: Phosphodiesterase 5/protein
kinase G signal governs stemness of prostate cancer stem cells
through Hippo pathway. Cancer Lett. 378:38–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Perez R, Wu N, Klipfel AA and Beart RW Jr:
A better cell cycle target for gene therapy of colorectal cancer:
Cyclin G. J Gastrointest Surg. 7:884–889. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Tominaga O1, Nita ME, Nagawa H, Fujii S,
Tsuruo T and Muto T: Expressions of cell cycle regulators in human
colorectal cancer cell lines. Jpn J Cancer Res. 88:855–860. 1997.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Shen HQ, Xiao YX, She ZY, Tan FQ and Yang
WX: A novel role of KIF3b in the seminoma cell cycle. Exp Cell Res.
352:95–103. 2017. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sherr CJ, Beach D and Shapiro GI:
Targeting CDK4 and CDK6: From discovery to therapy. Cancer Discov.
6:353–367. 2016. View Article : Google Scholar :
|
28
|
Asghar U, Witkiewicz AK, Turner NC and
Knudsen ES: The history and future of targeting cyclin-dependent
kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Oury F, Sumara G, Sumara O, Ferron M,
Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, et al:
Endocrine regulation of male fertility by the skeleton. Cell.
144:796–809. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Rao PM, Kelly DM and Jones TH:
Testosterone and insulin resistance in the metabolic syndrome and
T2DM in men. Nat Rev Endocrinol. 9:479–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Qi J, Tripathi M, Mishra R, Sahgal N,
Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, et
al: The E3 ubiquitin ligase Siah2 contributes to
castration-resistant prostate cancer by regulation of androgen
receptor transcriptional activity. Cancer Cell. 23:332–346. 2013.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Ito S, Ueda T, Ueno A, Nakagawa H,
Taniguchi H, Hongo F, Kamoi K, Okihara K, Kawauchi A and Miki T:
Paired box 2 upregulates androgen receptor gene expression in
androgen-independent prostate cancer. FEBS J. 281:4506–4518. 2014.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Wang RS, Yeh S, Tzeng CR and Chang C:
Androgen receptor roles in spermatogenesis and fertility: Lessons
from testicular cell-specific androgen receptor knockout mice.
Endocr Rev. 30:119–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Nakagawa H, Ueda T, Ito S, Shiraishi T,
Taniguchi H, Kayukawa N, Nakanishi H, Ushijima S, Kanazawa M,
Nakamura T, et al: Androgen suppresses testicular cancer cell
growth in vitro and in vivo. Oncotarget. 7:35224–35232. 2016.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Di Vizio D, Cito L, Boccia A, Chieffi P,
Insabato L, Pettinato G, Motti ML, Schepis F, D'Amico W, Fabiani F,
et al: Loss of the tumor suppressor gene PTEN marks the transition
from intra-tubular germ cell neoplasias (ITGCN) to invasive germ
cell tumors. Oncogene. 24:1882–1894. 2005. View Article : Google Scholar : PubMed/NCBI
|
36
|
McIver SC, Stanger SJ, Santarelli DM,
Roman SD, Nixon B and McLaughlin EA: A unique combination of male
germ cell miRNAs coordinates gonocyte differentiation. PLoS One.
7:e355532012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Gilbert DC, McIntyre A, Summersgill B,
Missiaglia E, Goddard NC, Chandler I, Huddart RA and Shipley J:
Minimum regions of genomic imbalance in stage I testicular
embryonal carcinoma and association of 22q loss with relapse. Genes
Chromosomes Cancer. 50:186–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wu P, Tian Y, Chen G, Wang B, Gui L, Xi L,
Ma X, Fang Y, Zhu T, Wang D, et al: Ubiquitin B: An essential
mediator of trichostatin A-induced tumor-selective killing in human
cancer cells. Cell Death Differ. 17:109–118. 2010. View Article : Google Scholar
|
39
|
Nenoi M: Induced accumulation of
polyubiquitin gene transcripts in HeLa cells after UV-irradiation
and TPA-treatment. Int J Radiat Biol. 61:205–211. 1992. View Article : Google Scholar : PubMed/NCBI
|
40
|
Finch JS, St John T, Krieg P, Bonham K,
Smith HT, Fried VA and Bowden GT: Overexpression of three ubiquitin
genes in mouse epidermal tumors is associated with enhanced
cellular proliferation and stress. Cell Growth Differ. 3:269–278.
1992.PubMed/NCBI
|
41
|
Ryu KY, Sinnar SA, Reinholdt LG, Vaccari
S, Hall S, Garcia MA, Zaitseva TS, Bouley DM, Boekelheide K, Handel
MA, et al: The mouse polyubiquitin gene Ubb is essential for
meiotic progression. Mol Cell Biol. 28:1136–1146. 2008. View Article : Google Scholar :
|
42
|
Ciechanover A and Schwartz AL: The
ubiquitin system: Pathogenesis of human diseases and drug
targeting. Biochim Biophys Acta. 1695:3–17. 2004. View Article : Google Scholar : PubMed/NCBI
|
43
|
Hoeller D and Dikic I: Targeting the
ubiquitin system in cancer therapy. Nature. 458:438–444. 2009.
View Article : Google Scholar : PubMed/NCBI
|